{"version":"1.0","type":"link","title":"Lysine methylation-mediated SMYD2 degradation by casticin sensitizes non-small-cell lung cancer cells to osimertinib therapy.","author_name":"Pan K 외","author_url":"https://prs-insight.online/author/Pan%20K","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/99397","thumbnail_width":1200,"thumbnail_height":630}